Genovate Biotechnology (Taiwan) Technical Analysis
| 4130 Stock | TWD 23.90 0.10 0.42% |
As of the 1st of February, Genovate Biotechnology retains the Downside Deviation of 1.34, risk adjusted performance of 0.0551, and Market Risk Adjusted Performance of 0.3633. Genovate Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genovate Biotechnology downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Genovate Biotechnology is priced fairly, providing market reflects its last-minute price of 23.9 per share.
Genovate Biotechnology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Genovate, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GenovateGenovate |
Genovate Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Genovate Biotechnology Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Genovate Biotechnology Trend Analysis
Use this graph to draw trend lines for Genovate Biotechnology Co. You can use it to identify possible trend reversals for Genovate Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Genovate Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Genovate Biotechnology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Genovate Biotechnology Co applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Genovate Biotechnology Co will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1.88, which is the sum of squared deviations for the predicted Genovate Biotechnology price change compared to its average price change.About Genovate Biotechnology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genovate Biotechnology Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genovate Biotechnology Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genovate Biotechnology price pattern first instead of the macroeconomic environment surrounding Genovate Biotechnology. By analyzing Genovate Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genovate Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genovate Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.
Genovate Biotechnology February 1, 2025 Technical Indicators
Most technical analysis of Genovate help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genovate from various momentum indicators to cycle indicators. When you analyze Genovate charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0551 | |||
| Market Risk Adjusted Performance | 0.3633 | |||
| Mean Deviation | 0.9138 | |||
| Semi Deviation | 1.02 | |||
| Downside Deviation | 1.34 | |||
| Coefficient Of Variation | 1692.93 | |||
| Standard Deviation | 1.9 | |||
| Variance | 3.59 | |||
| Information Ratio | 0.0176 | |||
| Jensen Alpha | 0.0822 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.0248 | |||
| Treynor Ratio | 0.3533 | |||
| Maximum Drawdown | 15.76 | |||
| Value At Risk | (1.32) | |||
| Potential Upside | 1.81 | |||
| Downside Variance | 1.8 | |||
| Semi Variance | 1.05 | |||
| Expected Short fall | (1.62) | |||
| Skewness | 2.86 | |||
| Kurtosis | 16.07 |
Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.